Crossmark

Integrated computational and preclinical evaluation of novel synthetic pyrazole pyrazoline thiazole derivative for breast cancer therapeutics

Published Online: 2025-08-26

Authors

Shah, Rushikumar

Kamani, Ronak

Raval, Dipak

Patel, Kirit

Prajapati, Vaibhav

Prajapati, Ronak

Dongre, Sanika

Shah, Umang

Patel, Alkeshkumar
License Information

Text and Data Mining valid from 2025-08-26

Version of Record valid from 2025-08-26
More Information

Article History

Received: 5 August 2024

Accepted: 11 December 2024

First Online: 26 August 2025

Declarations

:

: The authors declare no competing interests.

Document is current